8Indexed trials
drug · Product Intelligence
Duloxetine
Pipeline Intelligence
Duloxetine: 8 indexed trials, 8 sponsors; 1 linked Orange Book patents and 8 FDA-linked events where matched.
8Sponsors
1Orange Book patent links
8FDA-linked events
Development evidence
NCT00105989Eli Lilly and Company · depressionPHASE3
NCT00177671University of Pittsburgh · alzheimersPHASE4
NCT00603265Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · pain_neuropathyPHASE2
NCT00672620Takeda · depressionPHASE3
NCT01057329Medical University of Vienna · adhdCOMPLETED
NCT01309945Bristol-Myers Squibb · depressionPHASE2
NCT02857244University of Chicago · parkinsonsPHASE2
NCT03038867Weill Medical College of Cornell University · depressionPHASE2
FDA / patent evidence
12721817DULOXETINE HYDROCHLORIDE · app 2191312046-01-13
Regulatory context
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2026-02-27
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2019-08-16
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2019-04-17
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2017-03-23
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2015-10-28
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2015-08-26
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2014-06-09
FDA_APPROVALDULOXETINE HYDROCHLORIDE · 2013-12-11
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.